arginyl-glycyl-aspartic acid has been researched along with Blood Coagulation Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makowski, L; Olson-Sidford, W; W-Weisel, J | 1 |
| Chiang, HS; Huang, TF; Yang, RS | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Blood Coagulation Disorders
| Article | Year |
|---|---|
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.
Topics: Blood Coagulation Disorders; COVID-19; Humans; Integrins; Neovascularization, Pathologic; Oligopeptides; Protein Binding; Receptors, Virus; SARS-CoV-2; Signal Transduction; Spike Glycoprotein, Coronavirus; Virus Internalization | 2021 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Blood Coagulation Disorders
| Article | Year |
|---|---|
The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Apyrase; Blood Coagulation Disorders; Blood Coagulation Factors; Bone Neoplasms; Cell Adhesion; Enzyme Activation; Extracellular Matrix; Hirudins; Humans; Integrins; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Proteins; Oligopeptides; Osteosarcoma; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Binding; Thrombin; Tumor Cells, Cultured | 1995 |